Biochemical characterization and 1H NMR based metabolomics revealed Melicope lunu-ankenda leaf extract a potent anti-diabetic agent in rats

BMC Complementary and Alternative Medicine

Volumn 17, Issue 1, 2017, Pages

  AL Zuaidy, Mizher Hezam ^a,b   Mumtaz, Muhammad Waseem ^a,c   Hamid, Azizah Abdul ^a   Ismail, Amin ^a   Mohamed, Suhaila ^a   Razis, Ahmad Faizal Abdul ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b Center of Quality Control   (Iraq)

^c UNIVERSITY OF GUJRAT   (Pakistan)

Author keywords

1H Nmr; Anti diabetic; Melicope lunu ankenda extract; Metabolomics; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; MELICOPE LUNU ANKENDA EXTRACT; METFORMIN; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BIOCHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CITRIC ACID CYCLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MEGADOSE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY INJURY; LIPID METABOLISM; LOW DRUG DOSE; MALE; MELICOPE LUNU ANKENDA; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORGAN WEIGHT; PLANT LEAF; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RUTACEAE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; WEIGHT CHANGE; ANIMAL; BLOOD; CHEMISTRY; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; ENZYMOLOGY; KIDNEY; LIVER; METABOLISM; PHYTOTHERAPY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL, HDL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; KIDNEY; LIPIDS; LIVER; MALE; METABOLOMICS; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PROTON MAGNETIC RESONANCE SPECTROSCOPY; RATS, SPRAGUE-DAWLEY; RUTACEAE; TRIGLYCERIDES;

EID: 85021876424     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-017-1849-2     Document Type: Article

References (35)

1. Inzucchi S, Bergenstal R, Fonseca V, Ed G, Mayer-Davis B, Spollett G, et al. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Supplement 1):S81-S90.
2. Raza H, John A, Howarth FC. Increased metabolic stress in Zucker diabetic fatty rat kidney and pancreas. Cell Physiol Biochem. 2013;32(6):1610-20.
3. Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, et al. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int. 2005;68(6):2562-71.
4. Srinivasan K, Viswanad B, Lydia Asrat C, Kaul L, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52(4):313-20.
5. Zhang M, Xiao-Yan L, Jing L, Zhi-Gang X, Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res. 2009;2008:1-9.
6. Dunn WB, Goodacre R, Neyses L, Mamas M. Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook. Bioanalysis. 2011;3(19):2205-22.
7. Friedrich N. Metabolomics in diabetes research. J Endocrinol. 2012;215(1):29-42.
8. Hunter P. Reading the metabolic fine print. EMBO Rep. 2009;10(1):20-3.
9. Lanza R, Zhang S, Lawrence E, Ward K, Daniel R, Sreekumaran K. Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes. PLoS One. 2010;5(5):e10538.
10. Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2012;2(4):320-30.
11. Irondi A, Ganiyu O, Afolabi A, Aline B, Margareth A. Phenolics composition and antidiabetic property of Brachystegia eurycoma seed flour in high-fat diet, low-dose streptozotocin-induced type 2 diabetes in rats. Asian Pac J Trop Dis. 2015;5:S159-65.
12. Kassim NK, Rahmani M, Ismail A, Sukari MA, Ee GCL, Nasir NM, et al. Antioxidant activity-guided separation of coumarins and lignan from Melicope Glabra (Rutaceae). Food Chem. 2013;139(1):87-92.
13. Ramli I, Kamarulzaman NH, Shaari K. Ee*GCL: p-O-geranylcoumaric acid from Melicope lunu-ankenda. Nat Prod Res. 2004;18(4):289-94.
14. Tan LY, Yin W-F, Chan K-G. Silencing quorum sensing through extracts of Melicope lunu-ankenda. Sensors. 2012;12(4):4339-51.
15. Fauvel MT, Gleye J, Moulis C, Blasco F, Stanislas E. Alkaloids and flavonoids of Melicope Indica. Phytochemistry. 1981;20(8):2059-60.
16. Parsons IC, Gray AI, Hartley TG, Waterman PG. Acetophenones and coumarins from stem bark and leaves of Melicope Stipitata. Phytochemistry. 1994;37(2):565-70.
17. Al-Zuaidy MH, Hamid AA, Ismail A, Mohamed S, Razis A, Faizal A, et al. Potent Antidiabetic activity and metabolite profiling of Melicope Lunu-ankenda leaves. J Food Sci. 2016;81(5):C1080-90.
18. Zhang C-H, Xu G-L, Liu Y-H, Rao Y, Yu R-Y, Zhang Z-W, et al. Anti-diabetic activities of Gegen Qinlian decoction in high-fat diet combined with streptozotocin-induced diabetic rats and in 3T3-L1 adipocytes. Phytomedicine. 2013;20(3):221-9.
19. Mokiran NN, Ismail A, Azlan A, Hamid M, Hassan FA. Effect of dabai (Canarium odontophyllum) fruit extract on biochemical parameters of induced obese-diabetic rats. J Funct Foods. 2014;8:139-49.
20. Beckonert O, Keun HC, Ebbels TMD, Bundy J, Holmes E, Lindon JC, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2(11):2692-703.
21. Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikström C, Wold S. Multi-and Megavariate data analysis part I: basic principles and applications. Umea: Umetrics. Inc.; 2006. p. 243-92.
22. Ghasemzadeh A, Ghasemzadeh N. Flavonoids and phenolic acids: role and biochemical activity in plants and human. J Med Plants Res. 2011;5(31):6697-703.
23. Islam MS, Choi H, Loots DT. Effects of dietary onion (Allium cepa L.) in a high-fat diet streptozotocin-induced diabetes rodent model. Ann Nutr Metab. 2008;53(1):6-12.
24. Skovsø S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diab Investig. 2014;5(4):349-58.
25. Sathyadevi M, Suchithra ER, Subramanian S. Physalis peruviana Linn. Fruit extract improves insulin sensitivity and ameliorates hyperglycemia in high-fat diet low dose STZ-induced type 2 diabetic rats. J Pharm Res. 2014;8(4):625-32.
26. Wu L-Y, Juan C-C, Ho L-T, Hsu Y-P, Hwang LS. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem. 2004;52(3):643-8.
27. Wold LE, Ceylan-Isik AF, Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin. 2005;26(8):908-17.
28. Liu H, Wu C, Wang S, Gao S, Liu J, Dong Z, et al. Extracts and lignans of Schisandra Chinensis fruit alter lipid and glucose metabolism in vivo and in vitro. J Funct Foods. 2015;19:296-307.
29. George S, Nair SA, Johnson AJ, Venkataraman R, Baby S. O-prenylated flavonoid, an antidiabetes constituent in Melicope lunu-ankenda. J Ethnopharmacol. 2015;168:158-63.
30. Ismail NS. Protective effects of aqueous extracts of cinnamon and ginger herbs against obesity and diabetes in obese diabetic rat. World J Dairy Food Sci. 2014;9(2):145-53.
31. Ashish B, Swapnil G, Baldi A. Hypoglycemic effect of polyherbal formulation in alloxan induced diabetic rats. Pharmacologyonline. 2011;3:764-73.
32. Tian N, Wang J, Wang P, Song X, Yang M, Kong L. NMR-based metabonomic study of Chinese medicine Gegen Qinlian decoction as an effective treatment for type 2 diabetes in rats. Metabolomics. 2013;9(6):1228-42.
33. Mishra A, Bhatti R, Singh A, Ishar M. Ameliorative effect of cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Med. 2010;76(5):412-7.
34. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007;29(2):99-108.
35. 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. Anal Biochem. 2008;383(1):76-84.